Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD

被引:13
|
作者
Kaspar, Georgy [1 ]
Sanam, Kumar [1 ]
Gholkar, Gunjan [1 ]
Bianco, Nicole R. [2 ]
Szymkiewicz, Steven [2 ]
Shah, Dipak [3 ]
机构
[1] Michigan State Univ, Dept Cardiol, Providence Providence Pk Hosp, Coll Human Med, Southfield, MI 48075 USA
[2] ZOLL, Pittsburgh, PA USA
[3] Michigan State Univ, Dept Cardiac Electrophysiol, Providence Providence Pk Hosp, Coll Human Med, 16001 West Nine Mile Rd, Southfield, MI 48075 USA
关键词
Implantable cardioverter-defibrillator (ICD); Sudden cardiac arrest (SCA); Cardiac device infections (CDI); Wearable cardioverter defibrillator (WCD); SUDDEN CARDIAC DEATH; ELECTRONIC DEVICE INFECTIONS; AMERICAN-HEART-ASSOCIATION; UNITED-STATES; PERMANENT PACEMAKER; RISK-FACTORS; RATES; MANAGEMENT; PREVENTION; TECHNOLOGY;
D O I
10.1016/j.ijcard.2018.08.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To evaluate the effectiveness of wearable cardioverter defibrillator (WCD) use in protecting patients from sudden cardiac arrest (SCA) while they were treated in nonhospital settings until re-implantation of an Implantable cardioverter-defibrillator (ICD) was feasible. We sought to determine whether the WCD could be successfully utilized long term (>= 1 year) after ICD extraction in patients at continued risk of SCD in which ICD reimplantation was not practical. Background: ICDs have proven to improve mortality in patients for both secondary and primary prevention of SCA. Increased ICD implantation in older patients with comorbid conditions has resulted in higher rates of cardiac device infections. Currently, a wearable cardioverter defibrillator (WCD) is an alternative management for SCA prevention in specific cases. Methods: This a retrospective analysis based on consecutive WCD patients who underwent ICD explant due to device-related infections or mechanical reasons between April 2007 and July 2014. A total of 102 patients were identified from the national database maintained by ZOLL (Pittsburgh, PA, USA). We analyzed the reason for WCD use, demographic information, device data, compliance and duration of WCD use, detected arrhythmias and therapies, and reason for discontinuing WCD use. Results: In these longterm WCD users, average length of WCD use was 638 +/- 361 days. Nine patients (8.8%) had a sustained ventricular arrhythmia that was successfully resuscitated by the WCD. Six patients (5.8%) experienced inappropriate shocks. Two patients (1.9%) died of asystole events while wearing the WCD and an additional 10 patients died while not monitored by the WCD. Thirty-nine patients (38.2%) ended WCD use when a new ICD was implanted and 15 patients (14.7%) were still wearing the WCD at the time of analysis. Conclusions: We found that extending use of the WCD to >= 1 year is a safe and effective alternative treatment for patients with explanted ICDs who are not pacemaker dependent. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 50 条
  • [21] Use of a Wearable Cardioverter Defibrillator (WCD) to Protect Patients After ICD Explantation: Results From the National Registry
    Wan, Chingping
    Ellenbogen, Kenneth A.
    Love, Charles J.
    Deshpande, Sanjay
    Szymkiewicz, Steven J.
    CIRCULATION, 2015, 132
  • [22] LONG-TERM OUTCOME WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) THERAPY IN A MULTICENTER INVESTIGATOR-EDITED DATABASE
    LEHMANN, MH
    THOMAS, A
    JACKSON, K
    STEIRMAN, RT
    SHAH, M
    SCHUGER, C
    MEISSNER, MD
    MOSTELLER, R
    CIRCULATION, 1990, 82 (04) : 166 - 166
  • [23] Electrical Storm (ES) in patients with Implantable Cardioverter Defibrillator (ICD) - Long term follow-up
    Gepner, K.
    Maciag, A.
    Syska, P.
    Zajac, D.
    Lewandowski, M.
    Sterlinski, M.
    Szwed, H.
    EUROPEAN HEART JOURNAL, 2009, 30 : 281 - 281
  • [24] Long-term prognosis of patients with Brugada syndrome and an implanted cardioverter-defibrillator
    Dores, Helder
    Santos, Katya Reis
    Adragao, Pedro
    Costa, Francisco Moscoso
    Santos, Pedro Galvao
    Carmo, Pedro
    Cavaco, Diogo
    Morgado, Francisco Bello
    Mendes, Miguel
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2015, 34 (06) : 394 - 401
  • [25] Long-term quality of life and uncertainty in patients living with an implantable cardioverter defibrillator
    Flemme, I
    Edvardsson, N
    Hinic, H
    Jinhage, BM
    Dalman, M
    Fridlund, B
    HEART & LUNG, 2005, 34 (06): : 386 - 392
  • [26] Long-term adherence to a wearable for continuous behavioural activity measuring in the SafeHeart implantable cardioverter defibrillator population
    Frodi, Diana My
    Kolk, Maarten Z. H.
    Langford, Joss
    Knops, Reinoud
    Tan, Hanno L.
    Andersen, Tariq Osman
    Jacobsen, Peter Karl
    Risum, Niels
    Svendsen, Jesper Hastrup
    Tjong, Fleur V. Y.
    Diederichsen, Soren Zoega
    EUROPEAN HEART JOURNAL - DIGITAL HEALTH, 2024, 5 (05): : 622 - 632
  • [27] The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections
    L. Castro
    S. Pecha
    M. Linder
    J. Vogler
    N. Gosau
    C. Meyer
    S. Willems
    H. Reichenspurner
    S. Hakmi
    Journal of Cardiothoracic Surgery, 12
  • [28] The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections
    Castro, L.
    Pecha, S.
    Linder, M.
    Vogler, J.
    Gosau, N.
    Meyer, C.
    Willems, S.
    Reichenspurner, H.
    Hakmi, S.
    JOURNAL OF CARDIOTHORACIC SURGERY, 2017, 12
  • [29] Use of neurostimulation in a patient with an implantable cardioverter defibrillator (ICD)
    Natour, M.
    Morgil, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (43) : 2207 - 2211
  • [30] Wearable cardioverter defibrillator use in patients with chemotherapy-induced cardiotoxicity
    Bianco, N.
    Szymkiewicz, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S324 - S324